Skip to main content

People's life expectancy is increasing - and the world's population is growing. That is why high-quality medical care is becoming increasingly important. Fresenius worldwide aims to give as many people as possible access to healthcare and medicine.

We offer lifesaving and life-sustaining products and therapies in more than 90 countries. Our products are often used to treat people who are suffering from serious or chronic diseases. Our task is to ensure the safety and quality of our products and services and to meet the highest safety and quality standards for all processes and therapies.

Our product and service portfolio includes a comprehensive network of hospitals, modern dialysis procedures, post-acute care such as rehabilitation, and high-quality drugs and medical products. Our portfolio also includes digital health services, advanced therapies, and the expansion of primary care in emerging and developing countries.

Fresenius Kabi offers products and services for the therapy and care of critically and chronically ill patients. The extensive range of intravenously administered generic drugs and the biosimilars products with a focus on autoimmune diseases and oncology are affordable alternatives to original drugs. Fresenius Kabi thus gives patients access to modern, high-quality and affordable therapies. The product portfolio also includes clinical nutrition and infusion therapies as well as the associated medical devices for application. In the field of transfusion medicine and cell therapy, the company offers products for collection of blood components and extracorporeal therapies.

Fresenius Helios' acute care hospitals, outpatient clinics, and other healthcare facilities offer the full range of medical services. Our international hospital network enables Fresenius Helios to transfer knowledge between healthcare systems in Germany, Spain and Latin America with regard to affordable healthcare of high-quality, and with very high standards of service and patient experience.

Fresenius Medical Care supports the development of infrastructure for the care of people with kidney disease in order to provide affordable care to a growing number of patients. Innovative digital services and products help make it easier for patients to access healthcare services and provide greater flexibility. This vertically integrated organization is particularly advantageous in crisis situations and emergencies.

Fresenius Vamed is active worldwide in the service of patient health. This includes acute care, prevention, rehabilitation and nursing as well as improved access to healthcare services. The value chain of Fresenius Vamed encompasses the full life cycle of a healthcare facility. This high level of internal service integration and expertise enables us to offer access to healthcare globally at all levels of care.

Healthcare in crisis situations

As a healthcare Group, we have to be crisis-proof and respond flexibly in all areas: it is our task to enable unrestricted access to our services and seamless care for patients even under difficult conditions. To ensure this, we have established high-performance as well as resilient emergency systems and programs in our business segments.

On duty in disaster zones

Fresenius employees help patients and colleagues after devastating hurricanes.

Corporate social responsibility

The ambition to provide access to healthcare for as many people as possible worldwide and to continuously improve it is pursued by us with our social commitment. The Fresenius Group supports various regional or local initiatives that represent the interests of kidney patients. This includes emergency aid in crisis situations, e. g., through donations of dialysis machines and medical supplies, as well as with long-term measures such as Kidney Kid, an initiative to educate children about kidney health at an early age. In the U.S., Fresenius Kabi has a more than 10-year relationship with Americares. The business segment helps the non-profit organization support people impacted by poverty or disaster build better lives through better health. It does this through financial support and in-kind (product) donations for missions in both the U.S. and internationally. 


Sebastian Schlagwein

Head of Group ESG
T: +49 (0) 6172 608-2637

If you have any questions about sustainability, please contact us at the following address: